Deferiprone Market Size In 2021 is estimated to clock a modest CAGR of 1% during the forecast Period 2021-2027. Deperipron is an iron chelator indicated for the treatment of patients with transfusion iron overload due to thalassemia syndrome, primarily where current chelation therapies are insufficient. Chelation therapy is used to remove the build-up of toxic […]
Tag Archives: Deferiprone Market
Deferiprone market was 130 million US$ in 2017 and is expected to 750 million US$ by the end of 2027, growing at a CAGR of 24% between 2021 and 2027. Nerve damage can result from a blunt injury, such as a traction injury from a fall or car accident, or a sharp trauma such as […]